Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...
The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...
The Centers for Medicare & Medicaid Services has announced the selection of 15 prescription drugs for the third cycle of the ...
The U.S. government on Tuesday named the 15 new drugs targeted for Medicare price negotiations for 2028, including Gilead ...
Still, the medications in the latest round of negotiations — which now includes “Part B” drugs given in doctors offices — ...
The Centers for Medicare and Medicaid Services on Tuesday announced the first 10 prescription drugs that will be subject to Medicare price negotiations under the Inflation Reduction Act, a critical ...
Generic prescriptions allow patients to get the medicines they need at a lower price, without sacrificing the quality of treatment because, as we know, generic drugs are required by the FDA to be ...